High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience
José Rodríguez(The University of Texas MD Anderson Cancer Center), E. Condé(University of Bern), Juan José Lahuerta(Research Institute Hospital 12 de Octubre), Jesús F. San Miguel(Clinica Universidad de Navarra), M. Gandarillas(Marqués de Valdecilla University Hospital), Enric Carreras(Josep Carreras Leukaemia Research Institute), J. Rifón(Clinica Universidad de Navarra), J Zuazu(Institut Català d'Oncologia), Alberto Fernández de Sevilla(Duran i Reynals Hospital), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), J. Marín, José García‐Laraña, Marı́a Dolores Caballero(Complejo Hospitalario de Salamanca), Antonio Léon(Hospital Jerez Puerta del Sur), Antonio Gutiérrez(Hospital Universitario Son Dureta), R. Arranz(Hospital Universitario de La Princesa), Rosario Varela(Complexo Hospitalario Universitario A Coruña)
Cited by 129
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k